1. Home
  2. GAME vs COCH Comparison

GAME vs COCH Comparison

Compare GAME & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameSquare Holdings Inc.

GAME

GameSquare Holdings Inc.

HOLD

Current Price

$0.36

Market Cap

43.4M

Sector

N/A

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.66

Market Cap

53.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAME
COCH
Founded
2011
1995
Country
United States
United States
Employees
N/A
47
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
43.4M
53.4M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
GAME
COCH
Price
$0.36
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
811.1K
887.7K
Earning Date
04-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
65.14
N/A
EPS
N/A
N/A
Revenue
$44,999,302.00
N/A
Revenue This Year
$87.12
$1.58
Revenue Next Year
$21.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.36
52 Week High
$1.24
$1.89

Technical Indicators

Market Signals
Indicator
GAME
COCH
Relative Strength Index (RSI) 48.06 45.50
Support Level $0.37 $0.64
Resistance Level $0.48 $0.75
Average True Range (ATR) 0.03 0.07
MACD 0.01 -0.01
Stochastic Oscillator 52.49 15.18

Price Performance

Historical Comparison
GAME
COCH

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: